The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Thiruvananthapuram: Rajiv Gandhi Centre for Biotechnology (RGCB) was selected as one of the four next-generation sequencing (NGS) hubs for Metagenomic.

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Thiruvananthapuram: In a significant national recognition, the Kerala capital city-based Rajiv Gandhi Centre for ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Pillar Biosciences and AstraZeneca today announced an expansion of their existing laboratory access program for NGS-based ...

In a significant recognition of its scientific expertise, the Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) has been selected as one of four national hubs for Next-Generation Sequencing (NGS) ...

Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focusing on the application of next ...